Incretin Effect and Glucagon Responses to Oral and Intravenous Glucose in Patients With Maturity-Onset Diabetes of the Young—Type 2 and Type 3 - Østoft, Signe H.; Bagger, Jonatan I.; Hansen, Torben; Pedersen, Oluf; Holst, Jens J.; Knop, Filip K.; Vilsbøll, Tina (Diabetes (New York, N.Y.), 2014)
Keywords: Administration, Intravenous; Administration, Oral; Adult; Biological and medical sciences; Diabetes; Diabetes Mellitus, Type 2 - genetics; Diabetes Mellitus, Type 2 - metabolism; Diabetes. Impaired glucose tolerance; Effects; Endocrine pancreas. Apud cells (diseases); Endocrinopathies; Etiopathogenesis. Screening. Investigations. Target tissue resistance; Female; Gastric Emptying - drug effects; Gastric Emptying - physiology; Gastric Inhibitory Polypeptide - genetics; Gastric Inhibitory Polypeptide - metabolism; Gene Expression Regulation; Glucagon - metabolism; Glucagon-Like Peptide 1 - genetics; Glucagon-Like Peptide 1 - metabolism; Glucokinase - genetics; Glucokinase - metabolism; Glucose; Glucose - administration & dosage; Glucose - pharmacology; Hepatocyte Nuclear Factor 1-alpha - genetics; Hepatocyte Nuclear Factor 1-alpha - metabolism; Hormones; Humans; Incretins - metabolism; Insulin Resistance; Kinases; Male; Medical sciences; Middle Aged; Patients; Peptides; Endocrinopathy; Human; Incretin; Pancreatic hormone; Glucagon; Diabetes mellitus; Peptide hormone; Glucose